Biologic Agent

DRUG4 trials

Sponsors

Psoriasis Treatment Center of Central New Jersey, Royal College of Surgeons, Ireland, University Hospital Tuebingen, Qianfoshan Hospital

Conditions

ABPAAllergic Bronchopulmonary AspergillosisAllergic Bronchopulmonary Aspergillosis (ABPA)AsthmaBiologicsCohort StudyEfficacy and SafetyInflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)

Unknown Phase

An Outcomes Study to Determine the Reasons Patients on Biologic Therapy Discontinue Treatment and Fail to Follow-up With Their Providers

CompletedNCT03964168

Psoriasis Treatment Center of Central New JerseyPsoriasis

Start: 2019-07-31End: 2020-03-03Updated: 2020-03-11

This is a 6-month Observational Study. Patients Included Will be Those Referred With a Possible Diagnosis or an Established Diagnosis of Asthma. It Will Look at the Association of the Asthma Microbiome and Disease Characteristics, Severity and Treatment Response.

Royal College of Surgeons, IrelandAsthma

Start: 2023-10-31End: 2025-07-31Target: 60Updated: 2023-09-08

Molecular Inflammation Board at the Center for Personalized Medicine

RecruitingNCT07132333

University Hospital TuebingenInflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis), Psoriasis Arthritis, Psoriasis (PsO) +1

Start: 2022-11-16End: 2032-11-30Target: 3000Updated: 2025-08-20

A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA

RecruitingNCT07362693

Qianfoshan HospitalABPA, Allergic Bronchopulmonary Aspergillosis, Allergic Bronchopulmonary Aspergillosis (ABPA) +3

Start: 2025-01-31End: 2028-12-31Target: 50Updated: 2026-04-17